(Q48384178)

11 February 2018

title

The use of the activated clotting time for monitoring heparin therapy in critically ill patients (English)

1 reference

11 February 2018

1 reference

3

1 reference

11 February 2018

author name string

Jan J De Waele

1

1 reference

11 February 2018

Sebastiaan Van Cauwenberghe

2

1 reference

11 February 2018

Dominique Benoit

4

1 reference

11 February 2018

Francis Colardyn

5

1 reference

11 February 2018

publication date

16 January 2003

1 reference

11 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Intensive Care Medicine

1 reference

11 February 2018

volume

29

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

325-328

1 reference

11 February 2018

Deep vein thrombosis and its prevention in critically ill adults.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

A review of the clinical indications for the plasma heparin assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1609-7

Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time

21 January 2018

1 reference

12 December 2020

Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time

1 reference

12 December 2020

Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin

1 reference

12 December 2020

A Comparison of Five Devices for the Bedside Monitoring of Heparin Therapy

1 reference

12 December 2020

Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time

1 reference

12 December 2020

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes

1 reference

12 December 2020

1 reference

12 December 2020

The laboratory control of heparin therapy

1 reference

12 December 2020

Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy

1 reference

12 December 2020

10.1007/S00134-002-1609-7

Identifiers

DOI

0 references

1 reference

11 February 2018